SIA
TTOO

Sit Investment Associates’s T2 Biosystems, Inc TTOO Stock Holding History

Sit Investment Associates’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28
Closed -$374K – 557
2019
Q1 		$374K Hold
28
– – 0.01% 410
2018
Q4 		$428K Hold
28
– – 0.01% 403
2018
Q3 		$1.06M Buy
28
+13
+87% +$428K 0.03% 330
2018
Q2 		$575K Buy
+15
New +$569K 0.01% 403

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sit Investment Associates's TTOO Position: Q2 2019 in Review

Sit Investment Associates sold out of T2 Biosystems, Inc (TTOO) in Q2 2019, closing a stake of 28 shares — an estimated $374K sold.

Sit Investment Associates first reported a position in TTOO in Q2 2018 and held it in 4 quarters. The position peaked at $1.06M in Q3 2018. 63 funds tracked by Wall St. Rank hold TTOO as of Q2 2019.

  • Sit Investment Associates reported no remaining T2 Biosystems, Inc position as of Q2 2019 after selling out during the quarter.
  • Sit Investment Associates sold 28 T2 Biosystems, Inc shares in Q2 2019, an estimated $374K.
  • Sit Investment Associates first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 4 quarters.
  • Sit Investment Associates's T2 Biosystems, Inc position peaked at $1.06M in Q3 2018.
  • 63 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2019.

Based on Sit Investment Associates's 13F filing for Q2 2019, filed 14 Aug 2019.